GENERALQUIET
23 hours ago
FDA warns of rare ‘eye stroke’ risk from GLP-1 drugs
What's happening
SignalsMonitor is following this as a general story. The Hill is the outlet attached so far. The first report grouped here was at 9 Nov 2026, 21:33 UTC. The headline in use is “FDA warns of rare ‘eye stroke’ risk from GLP-1 drugs”. This note is SignalsMonitor's own briefing, not the publisher's article.
What we know
The Food and Drug Administration (FDA) on Monday required pharmaceutical companies to warn patients and healthcare providers of a potential increased risk of a serious eye condition associated with the use of GLP-1 drugs for weight loss and diabetes. Non-arteritic anterior ischemic optic neuropathy (NAION), often referred to as an…
The HillRead at The Hill
Story timeline
Reports grouped into this story, earliest first. Exact repeats from the same outlet are collapsed.
- First reported by The Hill
Reported by 1 outlet
- The Hill